Lindsey Knapke, MD
Gynecology · Grandview Heights, OHNPI 1447607932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.2% of the total.
Across 239 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$612
- Mayne Pharma Commercial LLC$609
- Agile Therapeutics, Inc.$339
- Optumhealth Care Solutions, LLC$260
- Biogen$220
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,07495%
- Education$1945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,075 |
| Astellas Pharma US Inc | 28 | $612 |
| Mayne Pharma Commercial LLC | 30 | $609 |
| Agile Therapeutics, Inc. | 24 | $339 |
| Optumhealth Care Solutions, LLC | 16 | $260 |
| Biogen | 14 | $220 |
| Exeltis, USA Inc. | 19 | $191 |
| Organon | 13 | $146 |
| Exact Sciences | 5 | $103 |
| Coopersurgical, Inc. | 5 | $101 |
| Channel Medsystems, Inc. | 1 | $82 |
| Millicent US Inc | 4 | $76 |
| Amgen | 4 | $71 |
| Merck | 4 | $70 |
| Pacira Pharmaceuticals Incorporated | 2 | $51 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Shield Therapeutics Inc | 2 | $30 |
| Octapharma USA, Inc. | 1 | $28 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Gynesonics, Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $18 |
| Minerva Surgical, Inc | 1 | $18 |
| Bayer | 1 | $14 |
| Pfizer | 1 | $14 |
| Aspira Women's Health Inc | 1 | $14 |
How this compares
$4,267 in reported general payments places this provider in the 80th percentile of 77 gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $737 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Grandview Heights
- Jessica MillerGrandview Heights$3K
- Derek VanamerongenCincinnati$316K
- Megan BillowCleveland$83K
- Rachel PopeCleveland$49K
- Rosanne Marie KhoCleveland$19K
- Joseph FranzeseCincinnati$18K
- Susan Clark-FrantzNorton$10K
- Amber Bondurant SullivanGahanna$8K
- Marianna VardakaCincinnati$8K
- Tarek DboukLorain$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.